Please provide your email address to receive an email when new articles are posted on . In an analysis of data from two phase 3, multicenter studies of 1,217 adult patients randomized to the ...
Richard Adler, MD, FACS, leads a discussion on real-world signs, symptoms and patient reactions associated with the treatment for DED. This is a video synopsis/summary of a Post Conference ...
Please provide your email address to receive an email when new articles are posted on . DENVER – Treatment with the mitochondrial reactive oxygen species scavenger Visomitin resulted in reduced ...
DALLAS - Aug. 20, 2007 - Lissamine green sounds like the latest cleaning sensation being hawked on television and probably not something you would want to get in your eyes. But a few properly placed ...
HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology ...
Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye ...
Oculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining plans to finalize a phase 3 study after seeing some signs of efficacy in a subpopulation in its ...
Outcomes after cataract surgery can be compromised by dry eye disease. Researchers at the American Society of Cataract & Refractive Surgery (ASCRS) annual meeting explored whether biologic corneal ...
A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and ...
The administration of low-level light therapy before and after cataract surgery relieved symptoms of dry eye, a frequent complication of the procedure. This noninvasive treatment also enhanced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results